Reminiscent of the TFIID-independent function of TAF3 in regulation of myogenesis (11–13), the transcriptional control of Inr-containing promoters by TAF1/TAF2 may be relevant in ovarian cancer, since TBP is predominantly downregulated in many HGSCs (2, 3). This evidence concerns the gene TAF2 and ovarian cancer.